By Canntab Therapeutics Ltd on Thursday, 01 November 2018
Category: Pharmaceutical - BioTech

Canntab Therapeutics signs deal to enter medicinal cannabis market in Mexico

viewCanntab Therapeutics Ltd

. () CFO Richard Goldstein checked in with Steve Darling from Proactive Investors on Skype to discuss Canntab entering in to a non binding Letter of Intent with Labsco Promedic SA de CV of Monterrey, Mexico. 

That deal is expected to be finalized by the end of the year. Goldstein also updated the companies most recent partnerships and how they are going to work. 

CSE:PILL

Market: CSE
Market Cap: $12.15 m
Follow

View company profile

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Canntab Therapeutics Ltd named herein, including the promotion by the Company of Canntab Therapeutics Ltd in any Content on the Site, the...

FOR OUR FULL DISCLAIMER CLICK HERE

Most read

Full interview: Exactus clinches two supply agreements

Exactus Inc (OTCMKTS:EXDI) CEO Emiliano Aloi tells Proactive it has entered into a supply and distribution agreement with Ceed2Med, as well as supplying hemp to Canntab Therapeutics Limited (CSE:PILL) (OTCMKTS:CTABF). Aloi says its an exciting venture and expects to push its products with...

on 11/26/2019

2 min read

Related Posts